Log in to your Inderes Free account to see all free content on this page.

Intervacc

1.14 SEK

-0.70%

Less than 1K followers

IVACC

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Intervacc

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue2.54.111.84.67.05.43.120.1
EBITDA-17.9-14.0-58.8-8.9-14.0-10.3-31.7-64.9
EBIT-22.5-18.5-77.3-13.5-18.6-15.0-36.4-83.5
EBIT-%-889.7 %-448.2 %-655.5 %-296.3 %-265.5 %-278.5 %-1,164.8 %-415.7 %
Profit before taxes-22.2-18.1-75.5-13.2-17.8-14.3-35.6-80.8
Net income-22.2-18.1-75.5-13.2-17.8-14.3-35.6-80.8
Login required

This content is only available for logged in users